1. Academic Validation
  2. Ginkgo biloba L. extract prevents steroid-induced necrosis of the femoral head by rescuing apoptosis and dysfunction in vascular endothelial cells via the PI3K/AKT/eNOS pathway

Ginkgo biloba L. extract prevents steroid-induced necrosis of the femoral head by rescuing apoptosis and dysfunction in vascular endothelial cells via the PI3K/AKT/eNOS pathway

  • J Ethnopharmacol. 2022 Oct 5;296:115476. doi: 10.1016/j.jep.2022.115476.
Fang Cao 1 Kai-Rong Qin 2 Kai Kang 3 Guoshuang Zheng 4 Weidan Wang 5 Xiuzhi Zhang 6 Dewei Zhao 7
Affiliations

Affiliations

  • 1 Department of Biomedical Engineering, Faculty of Electronic Information and Electronical Engineering, Dalian University of Technology, Dalian, China. Electronic address: caofang45500@163.com.
  • 2 Department of Optoelectronic Engineering and Instrumentation Science, Dalian University of Technology, Dalian, China. Electronic address: krqin@dlut.edu.cn.
  • 3 Department of Orthopedics, Affiliated Zhongshan Hospital of Dalian University, Dalian, China. Electronic address: kangkai140430@163.com.
  • 4 Department of Orthopedics, Affiliated Zhongshan Hospital of Dalian University, Dalian, China. Electronic address: zhengguoshuang@163.com.
  • 5 Department of Orthopedics, Affiliated Zhongshan Hospital of Dalian University, Dalian, China. Electronic address: wangweidan@dlu.edu.cn.
  • 6 Department of Orthopedics, Affiliated Zhongshan Hospital of Dalian University, Dalian, China. Electronic address: 18840810595@163.com.
  • 7 Department of Orthopedics, Affiliated Zhongshan Hospital of Dalian University, Dalian, China. Electronic address: zhaodewei2016@163.com.
Abstract

Ethnopharmacological relevance: Ginkgo biloba L. extract (EGb) is one of the world's most extensively used herbal medicines. Due to the diverse pharmacological properties of EGb, it has been used in the treatment of neurological illnesses, as well as cardiovascular and cerebrovascular ailments. However, the effect and pharmacological mechanism of EGb on steroid-induced necrosis of the femoral head (SINFH) are still unclear.

Aim of the study: SINFH remains a challenging problem in orthopedics. Previous investigations have shown that EGb has the potential to reduce the occurrence of SINFH. The goal was to determine the effect and mechanism of EGb in preventing SINFH by inhibiting Apoptosis and improving vascular endothelial cells (VECs) functions.

Materials and methods: CCK-8, nitric oxide (NO) production and flow cytometry were used to determine the cell Apoptosis and function. The scratch and angiogenesis tests assessed migration and tube formation. Western blot analysis detected the expressions of apoptosis-related proteins and PI3K/Akt/eNOS pathway-related proteins. Apoptosis and angiogenesis were also detected treated with the inhibitors. A mouse model of SINFH was established. Paraffin section was used to determine the necrotic pathology and Apoptosis. Vessels in the femoral heads were assessed by immunofluorescence staining.

Results: When stimulated by methylprednisolone (MPS), cell viability, NO generation and tube formation were decreased, the apoptotic rate increased. Simultaneously, MPS decreased the expression levels of p-PI3K, p-AKT, and p-eNOS. EGb increased the expression levels of these proteins, restrained Apoptosis, and restored cell functions. The addition of the inhibitors decreased anti-apoptotic effect and angiogenesis. In addition, when compared to the model mice, there were fewer empty lacunae and normal trabecular arrangement after taking different doses of EGb. The protective effect was also confirmed by the vascular quantitative analysis in vivo.

Conclusion: This study established that EGb increased endothelial cell activity and inhibited Apoptosis and function loss induced by MPS, elucidating the effect and molecular mechanism of EGb on early SINFH.

Keywords

Angiogenesis; Apoptosis; Ginkgo biloba L.; Glucocorticoid; Osteonecrosis; Vascular endothelial cell.

Figures
Products